FDA Inspection
Minaris Regenerative Medicine, LLCMinaris Regenerative Medicine, LLC – FDA Inspection, Jun 17, 2014
Record Details
This FDA Inspection record concerns Minaris Regenerative Medicine, LLC, with an inspection on June 17, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 17, 2014
- Product Type
- Biologics
View Company Profile
ID · 5a81bec9-2040-4d3a-a7ed-8fcfe398509d
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 886646
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Minaris Regenerative Medicine, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2025 | Not classified | New Jersey District Office | Human Cellular, Tissue, and Gene Therapies |
| September 25, 2023 | Not classified | New Jersey District Office | |
| August 26, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 26, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Minaris Regenerative Medicine, LLC
- FDA Inspection 1284408 - 2025-09-29
- FDA Inspection 1224145 - 2023-09-25
- FDA Inspection 1101234 - 2019-08-26
- FDA Inspection 1020396 - 2017-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.